Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon L Walmsley

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Antiviral Therapy|October 1, 2004
Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimensMona R Loutfy, Janet M Raboud, Sharon L Walmsley, et al.
AIDS and Behavior|July 21, 2017
Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation AnalysisTaylor McLinden, Erica E M Moodie, Anne-Marie Hamelin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
The Journal of Infectious Diseases|July 18, 2014
HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restrictionEszter Papp, Hakimeh Mohammadi, Mona R Loutfy, et al.
Open Forum Infectious Diseases|July 17, 2025
Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical TrialsSharon L Walmsley, Princy N Kumar, Chloe Orkin, et al.
Open Forum Infectious Diseases|April 6, 2016
Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort AnalysisCecilia T Costiniuk, Laurence Brunet, Kathleen C Rollet-Kurhajec, et al.
Pilot and Feasibility Studies|May 3, 2017
Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialKaitlin Siou, Sharon L Walmsley, Kellie E Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164)Sharon L Walmsley, Anona Thorne, Mona R Loutfy, et al.
HIV Clinical Trials|April 25, 2006
Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitisSharon L Walmsley, Janet Raboud, Jonathan B Angel, et al.
Plos One|July 28, 2021
Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppressionRodney K Rousseau, Leah Szadkowski, Colin M Kovacs, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Antiviral Therapy|October 1, 2004
Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimensMona R Loutfy, Janet M Raboud, Sharon L Walmsley, et al.
AIDS and Behavior|July 21, 2017
Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation AnalysisTaylor McLinden, Erica E M Moodie, Anne-Marie Hamelin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
The Journal of Infectious Diseases|July 18, 2014
HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restrictionEszter Papp, Hakimeh Mohammadi, Mona R Loutfy, et al.
Open Forum Infectious Diseases|July 17, 2025
Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical TrialsSharon L Walmsley, Princy N Kumar, Chloe Orkin, et al.
Open Forum Infectious Diseases|April 6, 2016
Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort AnalysisCecilia T Costiniuk, Laurence Brunet, Kathleen C Rollet-Kurhajec, et al.
Pilot and Feasibility Studies|May 3, 2017
Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialKaitlin Siou, Sharon L Walmsley, Kellie E Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164)Sharon L Walmsley, Anona Thorne, Mona R Loutfy, et al.
HIV Clinical Trials|April 25, 2006
Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitisSharon L Walmsley, Janet Raboud, Jonathan B Angel, et al.
Plos One|July 28, 2021
Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppressionRodney K Rousseau, Leah Szadkowski, Colin M Kovacs, et al.
Pageof 11